A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy

Pertti Jääskeläinen(University of Eastern Finland), Katriina Aalto‐Setälä(Tampere University), Keijo Peuhkurinen(University of Eastern Finland), Erkki Ilveskoski(Tampere University Hospital), Markku S. Nieminen(Cornell University), Satu Kärkkäinen(Kuopio University Hospital), Markku Laakso(Cleveland Clinic), Liisa Hämäläinen(Vaasa Central Hospital), John Melin(Central Finland Health Care District), Tiina Heliö(Helsinki University Hospital), Maija Kaartinen(Savonlinna Central Hospital)

Annals of Medicine

June 3, 2014

10.3109/07853890.2014.912834

Cited by 17

Related Papers

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

|The Lancet|2002|5.4k

FinnGen provides genetic insights from a well-phenotyped isolated population

|Nature|2023|4.2k

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

|The Lancet|2003|3.8k

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

|European Journal of Heart Failure|2008|3.5k

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

|European Heart Journal|2013|3.4k